Oniadba Nail Fungus Treatment Pen Liquid
NDC 85992-004
Product Information
Oniadba Nail Fungus Treatment Pen (tolnaftate,undecylenic acid) is a OTC MONOGRAPH DRUG-approved product labeled by Shenzhen Boyimei Technology Co., Ltd.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liquid for topical administration. This product entry covers the primary NDC 85992-004 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 85992-004?
What are the uses of this product?
What are Active Ingredients of this product?
- TOLNAFTATE 1 g/100mL - A synthetic antifungal agent.
- UNDECYLENIC ACID 25 g/100mL - Salts and derivatives of undecylenic acid.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLNAFTATE (UNII: 06KB629TKV)
- TOLNAFTATE (UNII: 06KB629TKV) (Active Moiety)
- UNDECYLENIC ACID (UNII: K3D86KJ24N)
- UNDECYLENIC ACID (UNII: K3D86KJ24N) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LAUROCAPRAM (UNII: 1F3X9DRV9X)
- CHLORHEXIDINE DIACETATE (UNII: 5908ZUF22Y)
- ALCOHOL (UNII: 3K9958V90M)
- CARAMEL (UNII: T9D99G2B1R)
- WATER (UNII: 059QF0KO0R)
- SORBITOL (UNII: 506T60A25R)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- ANGELICA DAHURICA ROOT (UNII: 1V63N2S972)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2691548 - tolnaftate 1 % / undecylenic acid 25 % Topical Solution
- RxCUI: 2691548 - tolnaftate 10 MG/ML / undecylenic acid 250 MG/ML Topical Solution
* Please review the full disclaimer at the bottom of this page.